Our study aimed to investigate the impact of inhibiting the ZC3H11A gene in cancer, particularly melanoma and colorectal carcinoma, using ASO as a tool to evaluate ZC3H11A function and evaluate ZC3H11A ASOs as a potential therapeutic agent. This evidence concerns the gene ZC3H11A and colorectal carcinoma.